Potential Use of the Anti-Inflammatory Drug, Sulfasalazine, for Targeted Therapy of Pancreatic Cancer
Potential Use of the Anti-Inflammatory Drug, Sulfasalazine, for Targeted Therapy of Pancreatic Cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Potential Use of the Anti-Inflammatory Drug, Sulfasalazine, for Targeted Therapy of Pancreatic Cancer have?
Potential Use of the Anti-Inflammatory Drug, Sulfasalazine, for Targeted Therapy of Pancreatic Cancer has 118 citations in the OpenAlex counts ScholarIQ stores.
When was Potential Use of the Anti-Inflammatory Drug, Sulfasalazine, for Targeted Therapy of Pancreatic Cancer published?
Potential Use of the Anti-Inflammatory Drug, Sulfasalazine, for Targeted Therapy of Pancreatic Cancer has 2010 year in the ScholarIQ index.
What is the open-access status of Potential Use of the Anti-Inflammatory Drug, Sulfasalazine, for Targeted Therapy of Pancreatic Cancer?
Potential Use of the Anti-Inflammatory Drug, Sulfasalazine, for Targeted Therapy of Pancreatic Cancer has gold oa status in the ScholarIQ index.
What is the DOI of Potential Use of the Anti-Inflammatory Drug, Sulfasalazine, for Targeted Therapy of Pancreatic Cancer?
The DOI for Potential Use of the Anti-Inflammatory Drug, Sulfasalazine, for Targeted Therapy of Pancreatic Cancer is on the source record.
What is the PMID of Potential Use of the Anti-Inflammatory Drug, Sulfasalazine, for Targeted Therapy of Pancreatic Cancer?
The PMID for Potential Use of the Anti-Inflammatory Drug, Sulfasalazine, for Targeted Therapy of Pancreatic Cancer is on the source record.
What is the OpenAlex record for Potential Use of the Anti-Inflammatory Drug, Sulfasalazine, for Targeted Therapy of Pancreatic Cancer?
The OpenAlex for Potential Use of the Anti-Inflammatory Drug, Sulfasalazine, for Targeted Therapy of Pancreatic Cancer is on the source record.